IESE Business School

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Psilocybin Therapy for Psychological Distress in Palliative Patients	Atypical Parkinson Disease, CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, autosomal dominant Parkinson disease 1, central nervous system disorder, chronic obstructive pulmonary disease, demyelinating disease, depressive disorder, immune system disorder, lung disorder, major depressive disorder, metabolic disease, mood disorder, motor neuron disorder, multiple sclerosis, nervous system disorder, neurodegenerative disease, neuromuscular disease, obstructive lung disease, proteostasis deficiencies, psychiatric disorder, respiratory system disorder, spinal cord disorder	Recruiting	Phase 2	2026-05-08		NCT06782724

Clinical trials